Olaparib in Treating Patients With Stage IV Pancreatic Cancer

Clinical trial NCT02677038 · COMPLETED

Trial details

NCT number: NCT02677038
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma Stage IV Pancreatic Cancer AJCC v6 and v7

Start date: 2016-11-11
Primary completion: 2022-07-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.